CLINICAL_TRIALS trial_result · 2011-06-01

Clinical Trial Update: Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma [Phase 2]

Phase 2 trial in a Bayer-sponsored study evaluating a treatment for unresectable stage III or stage IV melanoma; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bayer | Conditions: Cancer, Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2011-06-01